Inogen, Inc. (INGN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1156030,
    "name": "Inogen, Inc.",
    "stock_name": "Inogen, Inc.",
    "full_name": "Inogen, Inc.",
    "name_url": "stocks-analysis/inogen-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "6.99",
    "chg": 0.25,
    "chgp": "3.71%",
    "dir": 1,
    "prev_price": "6.74",
    "mcapval": "228.49",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US45780L1044",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "364.0 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/inogen-inc-1156030-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Inogen, Inc. Forms Golden Cross, Signaling Potential Bullish Breakout Ahead",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/inogen-inc-forms-golden-cross-signaling-potential-bullish-breakout-ahead-3617267",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/InogenInc_goldencross_3617267.png",
        "date": "2025-10-13 15:18:06",
        "description": "Inogen, Inc. has recently achieved a Golden Cross, indicating a potential shift in momentum. While short-term indicators suggest positive movement, the stock has faced challenges over the past year, underperforming the S&P 500. Investors are watching closely to see how these technical signals develop amid broader market conditions."
      },
      {
        "title": "Is Inogen, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-inogen-inc-technically-bullish-or-bearish-3547118",
        "imagepath": "",
        "date": "2025-09-20 19:47:33",
        "description": "As of 8 September 2025, the technical trend for Inogen, Inc. has changed from sideways to mildly bullish. The weekly MACD is bullish, and the monthly MACD is mildly bullish, supporting the positive outlook. Bollinger Bands are also bullish on both weekly and monthly time frames. However, daily moving averages indicate a mildly bearish stance, which tempers the overall bullish sentiment. The KST is bullish weekly but mildly bearish monthly, while Dow Theory shows a mildly bullish trend in both time frames. The On-Balance Volume is mildly bullish as well.\n\nInogen's recent performance shows a 1-week return of 2.69%, outperforming the S&P 500's 1.05%, and a strong 1-month return of 16.42% compared to the S&P 500's 2.33%. However, year-to-date and longer-term returns remain negative relative to the S&P 500. Overall, the current technical stance is mildly bullish, driven primarily by the positive MACD and Bolling..."
      },
      {
        "title": "Is Inogen, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-inogen-inc-overvalued-or-undervalued-3543554",
        "imagepath": "",
        "date": "2025-09-20 18:22:32",
        "description": "As of 24 February 2022, Inogen, Inc. has moved from an attractive to a risky valuation grade, indicating a significant deterioration in its financial outlook. The company is currently considered overvalued, as evidenced by its negative P/E ratio and poor return metrics. Key valuation ratios include a Price to Book Value of 0.90, an EV to EBITDA of -5.76, and an EV to Sales of 0.17, all of which suggest that the company is struggling to generate positive returns.\n\nInogen's peers, such as Bioventus, Inc. with a P/E of 72.81 and Semler Scientific, Inc. with a P/E of 32.26, highlight the disparity in valuation within the industry, as both are significantly outperforming Inogen. The company's recent stock performance has been disappointing, with a year-to-date return of -4.14% compared to the S&P 500's 12.22%, and a staggering 5-year return of -69.45% against the S&P 500's 96.61%, reinforcing the notion that Ino..."
      }
    ],
    "total": 8,
    "sid": "1156030",
    "stock_news_url": "https://www.marketsmojo.com/news/inogen-inc-1156030"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Inogen, Inc. Forms Golden Cross, Signaling Potential Bullish Breakout Ahead

2025-10-13 15:18:06

Inogen, Inc. has recently achieved a Golden Cross, indicating a potential shift in momentum. While short-term indicators suggest positive movement, the stock has faced challenges over the past year, underperforming the S&P 500. Investors are watching closely to see how these technical signals develop amid broader market conditions.

Is Inogen, Inc. technically bullish or bearish?

2025-09-20 19:47:33

As of 8 September 2025, the technical trend for Inogen, Inc. has changed from sideways to mildly bullish. The weekly MACD is bullish, and the monthly MACD is mildly bullish, supporting the positive outlook. Bollinger Bands are also bullish on both weekly and monthly time frames. However, daily moving averages indicate a mildly bearish stance, which tempers the overall bullish sentiment. The KST is bullish weekly but mildly bearish monthly, while Dow Theory shows a mildly bullish trend in both time frames. The On-Balance Volume is mildly bullish as well. Inogen's recent performance shows a 1-week return of 2.69%, outperforming the S&P 500's 1.05%, and a strong 1-month return of 16.42% compared to the S&P 500's 2.33%. However, year-to-date and longer-term returns remain negative relative to the S&P 500. Overall, the current technical stance is mildly bullish, driven primarily by the positive MACD and Bolling...

Is Inogen, Inc. overvalued or undervalued?

2025-09-20 18:22:32

As of 24 February 2022, Inogen, Inc. has moved from an attractive to a risky valuation grade, indicating a significant deterioration in its financial outlook. The company is currently considered overvalued, as evidenced by its negative P/E ratio and poor return metrics. Key valuation ratios include a Price to Book Value of 0.90, an EV to EBITDA of -5.76, and an EV to Sales of 0.17, all of which suggest that the company is struggling to generate positive returns. Inogen's peers, such as Bioventus, Inc. with a P/E of 72.81 and Semler Scientific, Inc. with a P/E of 32.26, highlight the disparity in valuation within the industry, as both are significantly outperforming Inogen. The company's recent stock performance has been disappointing, with a year-to-date return of -4.14% compared to the S&P 500's 12.22%, and a staggering 5-year return of -69.45% against the S&P 500's 96.61%, reinforcing the notion that Ino...

View All News